We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neutron Analysis of Glaucoma Drugs Could Help Aggressive Cancer Drug Design

News   Feb 13, 2018 | Original story from Oak Ridge National Laboratory

 
Neutron Analysis of Glaucoma Drugs Could Help Aggressive Cancer Drug Design

This image shows the active site of hCA II. The active site is flanked by hydrophilic (violet) and hydrophobic (green) binding pockets that can be used to design specific drugs targeting cancer-associated hCAs. Five clinical drugs are shown superimposed in the hCA II active site, based on room-temperature neutron structures. Credit: (ORNL/Andrey Kovalevsky)

 
 
 

RELATED ARTICLES

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

New Insights Could Change How Concussions Are Treated

News

New research questions the ongoing hypothesis that the blunt force behind a traumatic brain injury (TBI) causes nerve damage, or axonal injury. The findings could influence the treatment of and development of new drugs for TBI.

READ MORE

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE